BIOCONWAITING FOR PRICES TO TEST THE ENTRY PRICE. SELL SETUP :) KEEP IT SIMPLE, KEEP IT UNIQUE :) HAPPY TRADING, HAPPY PROFIT MAKING :) NOTE: MY VIEW ONLY.... Shortby UnknownUnicorn5589370
581 SAN; Reflex in progress as w2 of w3240 to 260 in 2 to 5 day of time SL compulsoryLongby WavozenUpdated 1
BIOCONIs in a sell mode gradually the stock has been slipping last many months one can short will stops at 256 for target of 238. In case of a good downward move it can slip to as low as 223 very fast filling the gap. Long players should avoid this.Shortby niftytrader3
#BIOCONBIOCON Sector: Healthcare Industry: Biotechnology & Medical Research Employees: 5005 Biocon Limited is a biopharmaceutical company. The Company focuses to reduce therapy costs of chronic diseases like autoimmune, diabetes, and cancer. Through its products and research services it is enabling access to affordable healthcare for patients, partners and healthcare systems across the globe. The Company has developed and taken a range of Novel Biologics, Biosimilars, differentiated Small Molecules and affordable Recombinant Human Insulin and Analogs from Lab to Market. The Company’s brands include INSUGEN (rh-insulin), BASALOG (Glargine), CANMAb (Trastuzumab), BIOMAb-EGFR (Nimotuzumab) and ALZUMAb (Itolizumab), an anti-CD6 monoclonal antibody. It has a pipeline of Biosimilars and Novel Biologics at various stages of development, including Insulin Tregopil, an oral insulin analog.Shortby TheInvestors115
BIOCON - short below 519 (18th May 2019)The demand supply zone on weekly chart is between 520-524. This zone is being tested for third time. In third test on 17th May price opened gapdown into the zone. Another point to be noted is it's gapdown open was within range of previous bar. The gap was ultimately filled in the same day. Close is within the zone. If open is above 524 , we can have short term buy. If open is below 519 , I would suggest a short with a target of 450 within a week.Shortby achalmeenaUpdated 1
Biocon Short"Biocon is expensive as compare to its competitors and its trading above its sector's PE ratio which is 50.65. biocon PE ratio is 64.71 which is alot higher than other pharma companies who is trading below PE ratio of 30. it will get its fair value soon. Advice : Stay short. Shortby illuminatist1
BIOCON Levels for tomorrow Rounding bottom formed on chart...as well can be a cup and handle can be formed.by Marketanalysis0
Biocon - 200EMABiocon has usually respected the 200EMA. Another retest might happen tomorrow. Lookout for another bounce off support (Go long w tight SL) or if it badly breaks down with high volumes then over the next few days it could give a short opportunity. by rdkriplani0
Resting on Retracement 583.85 - Next Target 669.50SL 557.35 if closes monthly above 669.50, Then next target 808 CCI34 Monthly is still above 100 CCI8 is below 0 - Nice Retracement view, must jump from here. Longby compudex2
BioconWild price move yesterday. Even though there is a very good news from USFDA for the new product. We wait for market to digest the new developments.Longby ParimalDevnath2